U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07367958) titled 'A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects' on Jan. 09.
Brief Summary: This is phase 1 study to Compare the Pharmacokinetics, Safety and Immunogenicity of the Auto-injector and Pre-filled syringe of CT-P52 in Healthy Male Subjects.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Male Subjects
Intervention:
BIOLOGICAL: CT-P52
CT-P52, 80 mg in 1 ml, a single subcutaneous (SC) injection via auto-injector (AI)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Celltrion
Published by HT Digital Content Services with permission from Health Daily Digest....